Investigating VCAM-1 Targeted Nanoparticles and Annexin A1 Therapy using Dysfunctional-endothelium-on-a-chip
S. Bazban-Shotorbani, M. Dufva, F. Gavins, N. Kamaly
This study uses a Dys-En-on-a-chip model to screen VCAM-1 targeting nanoparticles and test Annexin A1 therapy, finding nanoparticle size is key for targeting and Annexin A1 restores endothelial barrier function.
bioRxiv · May 9, 2021 · PreprintBioengineering